Literature DB >> 9659359

Lung infections. 3. Pseudomonas aeruginosa and other related species.

R Wilson1, R B Dowling.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9659359      PMCID： PMC1745165          DOI： 10.1136/thx.53.3.213

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  116 in total

1.  Intravenous antibiotic therapy in cystic fibrosis: in hospital or at home?

Authors:  D Peckham; A Knox
Journal:  Respir Med       Date:  1993-07       Impact factor: 3.415

Review 2.  The immunoevasive activities of Pseudomonas aeruginosa. Relevance for cystic fibrosis.

Authors:  A Buret; A W Cripps
Journal:  Am Rev Respir Dis       Date:  1993-09

3.  Cells and cytokines in chronic bronchial infection.

Authors:  J Eller; J R Lapa e Silva; L W Poulter; H Lode; P J Cole
Journal:  Ann N Y Acad Sci       Date:  1994-05-28       Impact factor: 5.691

Review 4.  New perspectives in understanding and management of the respiratory disease in cystic fibrosis.

Authors:  S Suter
Journal:  Eur J Pediatr       Date:  1994-03       Impact factor: 3.183

5.  Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells.

Authors:  L Saiman; A Prince
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

6.  Cytokines in sputum and serum from patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection as markers of destructive inflammation in the lungs.

Authors:  G Kronborg; M B Hansen; M Svenson; A Fomsgaard; N Høiby; K Bendtzen
Journal:  Pediatr Pulmonol       Date:  1993-05

7.  The quantitative distribution of nebulized antibiotic in the lung in cystic fibrosis.

Authors:  S Mukhopadhyay; G E Staddon; C Eastman; M Palmer; E R Davies; F Carswell
Journal:  Respir Med       Date:  1994-03       Impact factor: 3.415

8.  Immunization of noncolonized cystic fibrosis patients against Pseudomonas aeruginosa.

Authors:  S J Cryz; J Wedgwood; A B Lang; A Ruedeberg; J U Que; E Fürer; U B Schaad
Journal:  J Infect Dis       Date:  1994-05       Impact factor: 5.226

9.  Altered carbohydrate composition of salivary mucins from patients with cystic fibrosis and the adhesion of Pseudomonas aeruginosa.

Authors:  C Carnoy; R Ramphal; A Scharfman; J M Lo-Guidice; N Houdret; A Klein; C Galabert; G Lamblin; P Roussel
Journal:  Am J Respir Cell Mol Biol       Date:  1993-09       Impact factor: 6.914

10.  Novel Pseudomonas product stimulates interleukin-8 production in airway epithelial cells in vitro.

Authors:  P P Massion; H Inoue; J Richman-Eisenstat; D Grunberger; P G Jorens; B Housset; J F Pittet; J P Wiener-Kronish; J A Nadel
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808
View more
  23 in total

1.  Strain-dependent induction of neutrophil histamine production and cell death by Pseudomonas aeruginosa.

Authors:  Xiang Xu; Hong Zhang; Yuanlin Song; Susan V Lynch; Clifford A Lowell; Jeanine P Wiener-Kronish; George H Caughey
Journal:  J Leukoc Biol       Date:  2011-11-10       Impact factor: 4.962

2.  The Pseudomonas aeruginosa autoinducer N-3-oxododecanoyl homoserine lactone accelerates apoptosis in macrophages and neutrophils.

Authors:  Kazuhiro Tateda; Yoshikazu Ishii; Manabu Horikawa; Tetsuya Matsumoto; Shinichi Miyairi; Jean Claude Pechere; Theodore J Standiford; Masaji Ishiguro; Keizo Yamaguchi
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

3.  Increase in exhaled carbon monoxide during exacerbations of cystic fibrosis.

Authors:  J D Antuni; S A Kharitonov; D Hughes; M E Hodson; P J Barnes
Journal:  Thorax       Date:  2000-02       Impact factor: 9.139

4.  The type III pseudomonal exotoxin U activates the c-Jun NH2-terminal kinase pathway and increases human epithelial interleukin-8 production.

Authors:  Alayne Cuzick; Fiona R Stirling; Susan L Lindsay; Thomas J Evans
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

5.  Interaction of TonB with the outer membrane receptor FpvA of Pseudomonas aeruginosa.

Authors:  Hendrik Adams; Gabrielle Zeder-Lutz; Isabelle Schalk; Franc Pattus; Hervé Celia
Journal:  J Bacteriol       Date:  2006-08       Impact factor: 3.490

Review 6.  Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface.

Authors:  Sankalp Malhotra; Don Hayes; Daniel J Wozniak
Journal:  Clin Microbiol Rev       Date:  2019-05-29       Impact factor: 26.132

7.  Fast and simple epidemiological typing of Pseudomonas aeruginosa using the double-locus sequence typing (DLST) method.

Authors:  P Basset; D S Blanc
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-12-11       Impact factor: 3.267

8.  Bronchoalveolar fluid is not a major hindrance to virus-mediated gene therapy in cystic fibrosis.

Authors:  C P Rooney; G M Denning; B P Davis; D M Flaherty; J A Chiorini; J Zabner
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Accumulation of Pyrimidine Intermediate Orotate Decreases Virulence Factor Production in Pseudomonas aeruginosa.

Authors:  Abdurahman Niazy; Lee E Hughes
Journal:  Curr Microbiol       Date:  2015-04-28       Impact factor: 2.188

10.  tonB3 is required for normal twitching motility and extracellular assembly of type IV pili.

Authors:  Bixing Huang; Kelin Ru; Zheng Yuan; Cynthia B Whitchurch; John S Mattick
Journal:  J Bacteriol       Date:  2004-07       Impact factor: 3.490
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.